...
首页> 外文期刊>Hippocampus >Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
【24h】

Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.

机译:大鼠海马CA1锥体神经元中垂体腺苷酸环化酶激活多肽(PACAP)对AMPA受体介导的离子电流的调节。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pituitary adenylate cyclase-activating polypeptide (PACAP), a neurotrophic and neuromodulatory peptide, was recently shown to enhance NMDA receptor-mediated currents in the hippocampus (Macdonald, et al. 2005. J Neurosci 25:11374-11384). To check if PACAP might also modulate AMPA receptor function, we tested its effects on AMPA receptor-mediated synaptic currents on CA1 pyramidal neurons, using the patch clamp technique on hippocampal slices. In the presence of the NMDA antagonist D-AP5, PACAP (10 nM) reduced the amplitude of excitatory postsynaptic currents (EPSCs) evoked in CA1 pyramidal neurons by stimulation of Schaffer collaterals. Following a paired-pulse stimulation protocol, the paired-pulse ratio was unaffected in most neurons, suggesting that the AMPA-mediated EPSC was modulated by PACAP mainly at a postsynaptic level. PACAP also modulated the currents induced on CA1 pyramidal neurons by applications of either glutamate or AMPA. The effects of PACAP were dose-dependent: at a 0.5 nM dose, PACAP increased AMPA-mediated current; such effect was blocked by PACAP 6-38, a selective antagonist of PAC1 receptors. The enhancement of AMPA-mediated current by PACAP 0.5 nM was abolished when cAMPS-Rp, a PKA inhibitor, was added to the intracellular solution. At a 10 nM concentration, PACAP reduced AMPA-mediated current; such effect was not blocked by PACAP 6-38. The inhibitory effect of 10 nM PACAP was mimicked by Bay 55-9837 (a selective agonist of VPAC2 receptors), persisted in the presence of intracellular BAPTA and was abolished by intracellular cAMPS-Rp. Stimulation-evoked EPSCs in CA1 neurons were significantly reduced following application of the PAC1 antagonist PACAP 6-38; this result indicates that PAC1 receptors in the CA1 region are tonically activated by endogenous PACAP and enhance CA3-CA1 synaptic transmission. Our results show that PACAP differentially modulates AMPA receptor-mediated current in CA1 pyramidal neurons by activation of PAC1 and VPAC2 receptors, both involving the cAMP/PKA pathway; the functional significance will be discussed in light of the multiple effects exerted by PACAP on the CA3-CA1 synapse at different levels.
机译:垂体腺苷酸环化酶激活多肽(PACAP)是一种神经营养和神经调节肽,最近被证实可以增强海马中NMDA受体介导的电流(Macdonald等,2005。J Neurosci 25:11374-11384)。为了检查PACAP是否也可能调节AMPA受体功能,我们使用海马切片上的膜片钳技术测试了其对CA1锥体神经元上AMPA受体介导的突触电流的影响。在存在NMDA拮抗剂D-AP5的情况下,PACAP(10 nM)通过刺激Schaffer侧支降低了CA1锥体神经元诱发的兴奋性突触后电流(EPSC)的幅度。遵循成对脉冲刺激方案后,成对脉冲比率在大多数神经元中均不受影响,这表明AMPA介导的EPSC受PACAP的调节主要在突触后水平。 PACAP还通过应用谷氨酸盐或AMPA来调制在CA1锥体神经元上诱导的电流。 PACAP的作用是剂量依赖性的:在0.5 nM剂量下,PACAP可增加AMPA介导的电流。这种作用被PACAP受体的选择性拮抗剂PACAP 6-38阻断。当将cAMPS-Rp(一种PKA抑制剂)添加到细胞内溶液中时,由PACAP 0.5 nM增强的AMPA介导电流被消除。在10 nM的浓度下,PACAP降低了AMPA介导的电流。 PACAP 6-38并未阻止这种效果。 Bay 55-9837(VPAC2受体的选择性激动剂)模仿了10 nM PACAP的抑制作用,并在细胞内BAPTA存在的情况下持续存在,并被细胞内cAMPS-Rp消除。应用PAC1拮抗剂PACAP 6-38后,CA1神经元中的诱发性EPSC明显减少。该结果表明,CA1区的PAC1受体被内源性PACAP激活,并增强了CA3-CA1突触传递。我们的研究结果表明,PACAP通过激活PAC1和VPAC2受体(均涉及cAMP / PKA途径)来差异调节CA1锥体神经元中AMPA受体介导的电流。将根据PACAP对CA3-CA1突触在不同水平上发挥的多重作用来讨论其功能意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号